Answers are grounded in this paper and cite their sources.
HUMAN studies of several vaccines prepared from attenuated rubella virus have indicated their immunogenicity, noncommunicability and relative lack of untoward effects in children. Because a decrease or total loss of immunizing capacity has been noted with increase in the number of tissue-culture transfers carried out during attenuation,1,2 all the viruses now employed as vaccines have been carried through only a limited number of passages. Despite this, these preparations are not as antigenically active as the parent strains. Complement-fixing (CF) antibody rarely develops after their use, and hemagglutinin-inhibition (HI) and neutralizing-antibody titers are much lower than those that result from naturally . . .
No takes yet. Share an insight, caveat, or question.
Chang et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: